141.96
price down icon0.87%   -1.25
pre-market  Vorhandelsmarkt:  142.00   0.04   +0.03%
loading

Neurocrine Biosciences Inc Aktie (NBIX) Neueste Nachrichten

pulisher
04:53 AM

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Tredje AP fonden - MarketBeat

04:53 AM
pulisher
04:44 AM

Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherEarnings Performance Report & Weekly Stock Performance Updates - newser.com

04:44 AM
pulisher
04:22 AM

What earnings revisions data tells us about Neurocrine Biosciences Inc.Quarterly Profit Report & AI Driven Price Forecasts - newser.com

04:22 AM
pulisher
03:38 AM

What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com

03:38 AM
pulisher
03:24 AM

Can Neurocrine Biosciences Inc. stock weather global recession2025 Year in Review & Low Drawdown Momentum Ideas - newser.com

03:24 AM
pulisher
02:38 AM

Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyCPI Data & Stepwise Swing Trade Plans - newser.com

02:38 AM
pulisher
02:13 AM

Why Neurocrine Biosciences Inc. stock remains resilientInsider Selling & AI Enhanced Trading Alerts - newser.com

02:13 AM
pulisher
12:01 PM

Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo! Finance Canada

12:01 PM
pulisher
Nov 03, 2025

How Neurocrine Biosciences Inc. stock responds to policy changesJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Measuring Neurocrine Biosciences Inc.’s beta against major indices2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine Biosciences, Inc. (NBIX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 03, 2025
pulisher
Nov 03, 2025

Is Neurocrine Biosciences Inc. (NB3) stock vulnerable to rate hikes2025 Dividend Review & Verified Entry Point Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine taps China biotech for NLRP3 programs: Deals Report - BioCentury

Nov 03, 2025
pulisher
Nov 03, 2025

Key facts: JP Morgan Raises Neurocrine Target to $179; TransThera Deal Worth $881.5M - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine Bio. stock price target raised to $147 by BMO Capital - Investing.com Canada

Nov 03, 2025
pulisher
Nov 03, 2025

What data driven models say about Neurocrine Biosciences Inc.’s futureWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying sector rotation models to Neurocrine Biosciences Inc.Market Volume Report & Risk Adjusted Swing Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How big funds are accumulating Neurocrine Biosciences Inc. (NB3) stockJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine Biosciences (NBIX): Assessing Valuation After Strong Q3 Results and Pipeline Progress - simplywall.st

Nov 03, 2025
pulisher
Nov 03, 2025

Can Neurocrine Biosciences Inc. stock sustain revenue growth2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

What moving averages say about Neurocrine Biosciences Inc.Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

TransThera Sciences Sells NLRP3 Inhibitor License to Neurocrine Bioscience - MarketScreener

Nov 02, 2025
pulisher
Nov 02, 2025

Transthera Sciences (Nanjing) Inc announces collaboration with Neurocrine Biosciences Inc for NLRP3 inhibitors - MarketScreener

Nov 02, 2025
pulisher
Nov 02, 2025

Transthera Sciences (Nanjing) Inc Announces Collaboration With Neurocrine Biosciences Inc For NLRP3 Inhibitors - TradingView

Nov 02, 2025
pulisher
Nov 02, 2025

TransThera Sciences Partners with Neurocrine for NLRP3 Inhibitors Development - TipRanks

Nov 02, 2025
pulisher
Nov 02, 2025

How risky is Neurocrine Biosciences Inc. stock nowEarnings Miss & Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

1,945 Shares in Neurocrine Biosciences, Inc. $NBIX Purchased by Daymark Wealth Partners LLC - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

What analysts say about Neurocrine Biosciences Inc stockMarket Timing Techniques & Explosive Trading Portfolio - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Neurocrine Biosciences, Inc. (NBIX) Stock forecasts - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Is It Time to Lock in Profits on Winsol Engineers Limited StockPrice Volatility Patterns & Exceptional Trading Strategies - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Cantor Fitzgerald Brokers Raise Earnings Estimates for NBIX - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Brighton Jones LLC Invests $351,000 in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Short interest data insights for Neurocrine Biosciences Inc.Trade Analysis Report & Long-Term Safe Investment Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Neurocrine Biosciences, Inc. (NBIX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 31, 2025
pulisher
Oct 31, 2025

Neurocrine Biosciences (NASDAQ:NBIX) Given Buy Rating at Truist Financial - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Canaccord Genuity Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - MSN

Oct 31, 2025
pulisher
Oct 31, 2025

Neurocrine Biosciences Completes Phase 2 Study on NBI-1070770 for Depression - MSN

Oct 31, 2025
pulisher
Oct 31, 2025

Will Neurocrine Biosciences Inc. (NB3) stock return to pre crash levels2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is it time to cut losses on Neurocrine Biosciences Inc.2025 Market Sentiment & Verified Technical Trade Signals - newser.com

Oct 31, 2025
$10.53
price up icon 1.64%
$22.85
price up icon 3.16%
drug_manufacturers_specialty_generic RDY
$13.41
price up icon 0.90%
$44.39
price down icon 2.35%
$438.66
price down icon 1.52%
Kapitalisierung:     |  Volumen (24h):